# A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy Subjects

> **NCT03010475** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 41 (actual)

## Conditions studied

- Diabetes
- Healthy

## Interventions

- **DRUG:** Furosemide
- **DRUG:** Rosuvastatin
- **DRUG:** SNAC
- **DRUG:** Semaglutide

## Key facts

- **NCT ID:** NCT03010475
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-05
- **Primary completion:** 2017-06-04
- **Final completion:** 2017-08-09
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2017-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03010475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03010475, "A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy Subjects". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03010475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*